Member Info for Aberdeenman

Out today, CEO Dr Dan Gooding Remember this is run by World Renowned Scientists

New NFX BB already up and running. trols have already started there lol

Also worth noting the P/E ratio for the drug industry is around 24 So earnings of 41.67m will value this at �1B With a �Xm or �XXm deal in a few months, you dont need to be a world renowned scientist to work out where this is going. then NPX002!!! That is worth so much more Large pipeline of patents coming and very strong newsflow over the next few months LOVELY

I know you love this Inner REDUCED RISK Nuformix's approach uses existing drug molecules, with a history of safe use: No new safety data is required if staying within existing exposure limits, allowing rapid entry to both clinic and market Existing clinical data better informs decision making in future development Reduced time and cost of achieving clinical proof-of-concept and increasing success rates versus traditional biotech models NO NEW SAFETY DATA IS REQUIRED https://nuformix.com/pipeline/cocrystal-technology/strategic-benefits/

*L2

L@ looking VERY strong :-) Happy days

" Lower-risk human studies will provide validation to support out-licensing and further development by pharmaceutical partners "

Peds, try prefix with LSE, as there is a NYSE:NFX. System may be confused

Also like this bit (from RNS)....they don't even call them trials, just human studies... Spoke with the CEO on Friday at the EGM, As the existing drugs are well known and have been around and in use for many years, having gone through many trials, the cocrystal version is deemed to be safe, and require minimal testing (24 hours tests on 12 volunteers') Should be done and dusted in a few months

Early licensing revenues allow Nuformix to self-fund future discovery and development and build greater value into our pipeline

As per RNS ticker is NFX If in doubt a call to broker should sort it.

Also like this bit (from RNS)....they don't even call them trials, just human studies... Spoke with the CEO on Friday at the EGM, As the existing drugs are well known and have been around and in use for many years, having gone through many trials, the cocrystal version is deemed to be safe, and require minimal testing (24 hours tests on 12 volunteers') Should be done and dusted in a few months

Early licensing revenues allow Nuformix to self-fund future discovery and development and build greater value into our pipeline

20p is only a 5 bagger. Given this has gone from a shell to a company that could be sold further down the line for ~$1B, a major rerate is inevitable. 20p will do for starters, not selling there though... wait till 50p before I get a little temptation

No idea but hoping for 20p this week

REDUCED RISK Nuformix's approach uses existing drug molecules, with a history of safe use: No new safety data is required if staying within existing exposure limits, allowing rapid entry to both clinic and market Existing clinical data better informs decision making in future development Reduced time and cost of achieving clinical proof-of-concept and increasing success rates versus traditional biotech models NO NEW SAFETY DATA IS REQUIRED https://nuformix.com/pipeline/cocrystal-technology/strategic-benefits/

For those that are ignorant here... Regulatory Advantages Regulatory bodies treat drug cocrystals exactly as the pure drug: Drug substance has new physical properties only � its pharmacological activity is unchanged Therefore, drug cocrystals are applicable globally for both generic and abbreviated approval pathways US FDA Guidelines, April 2016: Cocrystals are classified as analogous to a new drug polymorph EMA Guidlines, May 2015: Cocrystals are treated as the same active substance as the original drug As the existing drugs are well known and have been around and in use for many years, having gone through many trials, the cocrystal version is deemed to be safe, and require minimal testing (24 hours tests on 12 volunteers') Very very clever, and will be very very valuable. First to market generics, with IP protection on the generic) in multi $B markets. https://nuformix.com/pipeline/cocrystal-technology/strategic-benefits/

Every man or woman for themselves from 8AM Shares transferring from profit takers into sticky hands, reducing the tiny free float even further. All major stock holders have voluntarily locked themselves in for 9 - 15 months, including Spreadex. They know what is coming.

For those that are ignorant here... Regulatory Advantages Regulatory bodies treat drug cocrystals exactly as the pure drug: Drug substance has new physical properties only � its pharmacological activity is unchanged Therefore, drug cocrystals are applicable globally for both generic and abbreviated approval pathways US FDA Guidelines, April 2016: Cocrystals are classified as analogous to a new drug polymorph EMA Guidlines, May 2015: Cocrystals are treated as the same active substance as the original drug As the existing drugs are well known and have been around and in use for many years, having gone through many trials, the cocrystal version is deemed to be safe, and require minimal testing (24 hours tests on 12 volunteers') Very very clever, and will be very very valuable. First to market generics, with IP protection on the generic) in multi $B markets. https://nuformix.com/pipeline/cocrystal-technology/strategic-benefits/

Yea the PK bit is 12 volunteers half taking Placebo half Nuformix drugs for 24 hours. Data analysed for a couple of days and results written up over another few. Had this conversation with the CEO on Friday. NO NEW SAFETY DATA IS REQUIRED, it is on their website.